Skip to main content
. 2023 Oct 24;2023(10):CD014967. doi: 10.1002/14651858.CD014967.pub2

CTRI/2014/06/004659.

Study name Levetiracetam vs phenobarbitone for the control of neonatal seizures: a double‐blind randomised controlled trial
Methods RCT
Participants Neonates (> 32 weeks) with clinical seizures
Interventions LEV 20‐60 mg/kg, vs PB 20‐40 mg
Outcomes Time until seizure control, mortality, mortality, neurodevelopment at 18 months, adverse events (not specified)
Starting date 2014
Contact information skb.bmc@gmail.com
Notes Expected sample size 300; entry last updated 2014